期刊文献+

口服钆喷酸葡胺在3.0T MR胰胆管成像中的应用

Application of Oral Gadopentetic Acid Dimeglumone Salt Solution in Magnetic Resonance Cholangiopancreatography at 3.0T MR
下载PDF
导出
摘要 目的探讨钆喷酸葡胺作为胃肠道阴性对比剂在3.0T磁共振胰胆管成像中的应用价值。方法对39例病人分别在口服钆喷酸葡胺前后进行磁共振胰胆管成像检查,得到两组对照图像,请放射科3位高年资医生对两组图像进行评估后行统计学分析。结果采用χ2检验分析,χ2值为62,P<0.001,两组差异具有显著性意义。结论口服钆喷酸葡胺后行磁共振胰胆管成像,图像中胃肠道液体信号几乎完全被抑制,既经济又方便,在磁共振胰胆管成像中更应该值得推广应用。 Objective:To investigate the value of oral gadopentetic acid dimeglumone salt solution as a negative gastrointestinal contrast agent in 3.0T magnetic resonance cholangiopancreatography. Methods: Thirty-nine patients were studied. Routine MRCP were performed on the same patients in the two groups before and after taking oral gadopentetic acid dimeglumone salt solution. Three experienced radiologists evaluated the images,and analyzed with statistical software. Resuits:The differences between the two groups were statistically significant(x^2= 62,P〈0.001). Conclusion: MRCP with oral gadopentetic acid dimeglumone salt solution shows the suppression of water signal from the gastrointestinal tract. It is an economical and convenient method that can be used in magnetic resonance cholangiopancreatography.
出处 《放射学实践》 2005年第10期924-926,共3页 Radiologic Practice
关键词 磁共振胰胆管成像 对比剂 质量控制 Magnetic resonance cholangiopancreatography Contrast medium Quality control
  • 相关文献

参考文献2

二级参考文献10

  • 1Takehara Y. Can MRCP replace ERCP? J Magn Reson Imaging,1998,8:517-534.
  • 2Hintze RE, Adler A, Veltzke W, et al. Clinical significance of magnetic resonance cholangiopancreatography (MRCP) compared to endoscopic retrograde cholangiopancreatography (ERCP).Endoscopy, 1997,29:182-187.
  • 3Irie H, Honda H, Kuroiwa T, et al. pitfall in MR cholangiopancreatographic interpretation. Radiology,2001,21:23-27.
  • 4Watanabe Y, Dohke M, Ishimori T, et al. Diagnostic pitfalls of MR cholangiopancreatography in the evaluation of the biliary tract and gallbladder. RadioGraphics, 1999, 19:415-429.
  • 5Kondo H, Kanematsu M, Shiratori Y,et al. Potential pitfalls of MR cholangiopancreatography: right hepatic arterial impression of the common hepatic duct. J Comput Assist Tomogr,1999, 23:60-62.
  • 6David V, Reinhold C, Hochman M, et al. Pitfalls in the interpretation of MR cholangiopancreatography. AJR, 1998,170:1055-1059.
  • 7Yuji W, Masako D, Takayoshi I, et al. Pseudo-obstruction of the extrahepatic bile duct due to artifact from arterial pulsatile compression: a diagnostic pitfall of MR cholangiopancreatography. Radiology, 2000, 214:856-860.
  • 8Reuther G, Kiefer B, TuchmannA, et al. Imaging finds of pancreatobilliary duct disease with single-shot MR cholangiopancreatography. AJR, 1997,168:453-459.
  • 9Hirohashi S, Hirohashi R, et al. MR cholangiopancreatography and MR urography: improved enhancement with a negative oral contrast agent. Radiology, 1997,203:281-285.
  • 10Hiraishi K, Narabayashi I Fujits O, et al. Blueberry juice: preliminary evaluation as an oral contrast agent in gastrointestinal MR imaging. Radiology, 1995,194:119-123.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部